Saphris Related Clinical Trials
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896 AM1) [Recruiting]
Once-Daily Asenapine for Schizophrenia [Not yet recruiting]
Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125) [Recruiting]
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM3) [Recruiting]
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692AM2) [Recruiting]
Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691 AM3) [Recruiting]
An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder [Recruiting]
Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384 AM3) [Recruiting]
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897 AM2 EXT) [Recruiting]
Asenapine in the Treatment of Older Adults With Bipolar Disorder [Recruiting]
Treating Acutely Agitated Patients With Asenapine Sublingual Tablets [Not yet recruiting]
A Study to Evaluate the Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (Study P06522) [Recruiting]
An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308 AM1) [Not yet recruiting]
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering [Not yet recruiting]
6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Subjects With an Acute Exacerbation of Schizophrenia (Study P06124 AM3) [Recruiting]
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression [Not yet recruiting]
A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688 AM2) [Recruiting]
Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM1) [Recruiting]
Observational Post-Authorisation Safety Study of Asenapine (Sycrest) [Recruiting]
Long-term Study of Asenapine in Subjects With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238 AM4) [Recruiting]
Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307 AM2) [Not yet recruiting]
Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics [Recruiting]
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis [Recruiting]
|
